Maria Sharapova Fails Drug Test
In a shocking revelation, five-time grand slam champion, Maria Sharapova admitted in a press conference, earlier today, that she failed a drug test during the Australian Open. Sharapova stated that she received a letter informing her that during the Australian Open she tested positive for the banned substance meldonium.
Meldonium, a drug used mostly in European countries, treats heart problems and help the circulation of oxygen in the body. Sharapova stated that she had been using the drug for ten years for health reasons and was unaware that it became a banned substance as of Jan 1, 2016.
In her press conference, Sharapova went on to state that she takes full responsibility for the oversight and will accept the consequences for her actions. With that said, Sharapova hopes this “mistake” doesn’t prevent her from continuing to play tennis or tarnish her tennis career.
Sharapova’s punishment is at the full discretion of the International Tennis Federation, ITF. The ITF can decide to punish Sharapova for multiple years or go easy on her and give her a minimal sanction if they believe it was an honest mistake.
The ITF has already determined that Sharapova will be suspended starting March 12, while they make their final decision.